Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:August 10, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:August 10, 2017Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:September 16, 2013Completed
Condition(s):Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative NeoplasmsLast Updated:May 25, 2017Completed
Condition(s):Mature B-Cell LymphomaLast Updated:March 25, 2024Active, not recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:February 28, 2023Active, not recruiting
Condition(s):Colitis, UlcerativeLast Updated:February 22, 2024Recruiting
Condition(s):Childhood EpendymomaLast Updated:September 15, 2023Recruiting
Condition(s):Acute Myeloid Leukemia; Acute Lymphoid Leukemia; Mixed Phenotype Acute Leukemia; Undifferentiated Leukemia; High-risk Myelodysplastic Syndrome; Acute Leukemia; Therapy-Related Myelodysplastic Syndrome; MDSLast Updated:September 26, 2023Recruiting
Condition(s):Acute Myeloid Leukemia in ChildrenLast Updated:February 16, 2024Recruiting
Condition(s):Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Long-term Effects Secondary to Cancer Therapy in Children; OtotoxicityLast Updated:September 20, 2013Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.